vs

Side-by-side financial comparison of Pennant Group, Inc. (PNTG) and INNOVATE Corp. (VATE). Click either name above to swap in a different company.

INNOVATE Corp. is the larger business by last-quarter revenue ($382.7M vs $289.3M, roughly 1.3× Pennant Group, Inc.). Pennant Group, Inc. runs the higher net margin — 3.0% vs -1.9%, a 4.9% gap on every dollar of revenue. On growth, INNOVATE Corp. posted the faster year-over-year revenue change (61.7% vs 53.2%). Over the past eight quarters, Pennant Group, Inc.'s revenue compounded faster (35.8% CAGR vs 10.2%).

The Pennant Group, Inc. is a U.S.-headquartered healthcare services provider that delivers home health care, hospice services, senior living solutions, and skilled nursing support. It operates across dozens of U.S. states, serving primarily elderly and medically vulnerable populations through its network of localized care facilities.

Innovate Corp. is an American public financial services company founded in 1994.

PNTG vs VATE — Head-to-Head

Bigger by revenue
VATE
VATE
1.3× larger
VATE
$382.7M
$289.3M
PNTG
Growing faster (revenue YoY)
VATE
VATE
+8.6% gap
VATE
61.7%
53.2%
PNTG
Higher net margin
PNTG
PNTG
4.9% more per $
PNTG
3.0%
-1.9%
VATE
Faster 2-yr revenue CAGR
PNTG
PNTG
Annualised
PNTG
35.8%
10.2%
VATE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PNTG
PNTG
VATE
VATE
Revenue
$289.3M
$382.7M
Net Profit
$8.6M
$-7.4M
Gross Margin
15.4%
Operating Margin
6.0%
3.7%
Net Margin
3.0%
-1.9%
Revenue YoY
53.2%
61.7%
Net Profit YoY
50.0%
55.4%
EPS (diluted)
$0.25
$-0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PNTG
PNTG
VATE
VATE
Q4 25
$289.3M
$382.7M
Q3 25
$229.0M
$347.1M
Q2 25
$219.5M
$242.0M
Q1 25
$209.8M
$274.2M
Q4 24
$188.9M
$236.6M
Q3 24
$180.7M
$242.2M
Q2 24
$168.7M
$313.1M
Q1 24
$156.9M
$315.2M
Net Profit
PNTG
PNTG
VATE
VATE
Q4 25
$8.6M
$-7.4M
Q3 25
$6.1M
$-8.9M
Q2 25
$7.1M
$-19.8M
Q1 25
$7.8M
$-24.5M
Q4 24
$5.8M
$-16.6M
Q3 24
$6.2M
$-15.0M
Q2 24
$5.7M
$14.4M
Q1 24
$4.9M
$-17.4M
Gross Margin
PNTG
PNTG
VATE
VATE
Q4 25
15.4%
Q3 25
14.3%
Q2 25
18.8%
Q1 25
16.6%
Q4 24
19.6%
Q3 24
19.9%
Q2 24
21.0%
Q1 24
15.4%
Operating Margin
PNTG
PNTG
VATE
VATE
Q4 25
6.0%
3.7%
Q3 25
4.5%
1.8%
Q2 25
5.3%
2.0%
Q1 25
6.0%
1.2%
Q4 24
4.9%
1.1%
Q3 24
6.0%
2.4%
Q2 24
5.7%
9.2%
Q1 24
5.4%
0.9%
Net Margin
PNTG
PNTG
VATE
VATE
Q4 25
3.0%
-1.9%
Q3 25
2.7%
-2.6%
Q2 25
3.2%
-8.2%
Q1 25
3.7%
-8.9%
Q4 24
3.0%
-7.0%
Q3 24
3.4%
-6.2%
Q2 24
3.4%
4.6%
Q1 24
3.1%
-5.5%
EPS (diluted)
PNTG
PNTG
VATE
VATE
Q4 25
$0.25
$-0.57
Q3 25
$0.17
$-0.71
Q2 25
$0.20
$-1.67
Q1 25
$0.22
$-1.89
Q4 24
$0.16
$-0.72
Q3 24
$0.20
$-1.18
Q2 24
$0.18
$1.03
Q1 24
$0.16
$-2.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PNTG
PNTG
VATE
VATE
Cash + ST InvestmentsLiquidity on hand
$112.1M
Total DebtLower is stronger
$168.8M
$80.3M
Stockholders' EquityBook value
$374.3M
$-240.1M
Total Assets
$968.2M
$950.1M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PNTG
PNTG
VATE
VATE
Q4 25
$112.1M
Q3 25
$35.5M
Q2 25
$33.4M
Q1 25
$33.3M
Q4 24
$48.8M
Q3 24
$51.0M
Q2 24
$80.2M
Q1 24
$38.4M
Total Debt
PNTG
PNTG
VATE
VATE
Q4 25
$168.8M
$80.3M
Q3 25
$26.0M
$97.3M
Q2 25
$37.0M
$160.1M
Q1 25
$52.5M
$139.9M
Q4 24
$0
$500.6M
Q3 24
$108.9M
$502.4M
Q2 24
$82.2M
$638.3M
Q1 24
$83.3M
$641.5M
Stockholders' Equity
PNTG
PNTG
VATE
VATE
Q4 25
$374.3M
$-240.1M
Q3 25
$343.0M
$-233.3M
Q2 25
$333.6M
$-224.8M
Q1 25
$323.0M
$-204.2M
Q4 24
$312.0M
$-180.4M
Q3 24
$187.3M
$-163.1M
Q2 24
$173.0M
$-149.0M
Q1 24
$164.2M
$-184.4M
Total Assets
PNTG
PNTG
VATE
VATE
Q4 25
$968.2M
$950.1M
Q3 25
$753.6M
$913.2M
Q2 25
$751.4M
$890.9M
Q1 25
$743.6M
$868.0M
Q4 24
$679.5M
$891.1M
Q3 24
$646.8M
$897.2M
Q2 24
$602.5M
$898.9M
Q1 24
$578.2M
$943.5M
Debt / Equity
PNTG
PNTG
VATE
VATE
Q4 25
0.45×
Q3 25
0.08×
Q2 25
0.11×
Q1 25
0.16×
Q4 24
0.00×
Q3 24
0.58×
Q2 24
0.48×
Q1 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PNTG
PNTG
VATE
VATE
Operating Cash FlowLast quarter
$21.0M
$101.1M
Free Cash FlowOCF − Capex
$17.4M
FCF MarginFCF / Revenue
6.0%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
2.43×
TTM Free Cash FlowTrailing 4 quarters
$36.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PNTG
PNTG
VATE
VATE
Q4 25
$21.0M
$101.1M
Q3 25
$13.9M
$19.2M
Q2 25
$34.6M
$40.4M
Q1 25
$-21.2M
$-14.1M
Q4 24
$20.6M
$41.4M
Q3 24
$7.7M
$-28.4M
Q2 24
$10.5M
$21.5M
Q1 24
$545.0K
$-25.4M
Free Cash Flow
PNTG
PNTG
VATE
VATE
Q4 25
$17.4M
Q3 25
$10.5M
$19.0M
Q2 25
$31.6M
Q1 25
$-23.2M
$-18.8M
Q4 24
$17.2M
$34.2M
Q3 24
$6.8M
$-31.5M
Q2 24
$8.9M
$18.4M
Q1 24
$-2.6M
$-31.0M
FCF Margin
PNTG
PNTG
VATE
VATE
Q4 25
6.0%
Q3 25
4.6%
5.5%
Q2 25
14.4%
Q1 25
-11.1%
-6.9%
Q4 24
9.1%
14.5%
Q3 24
3.8%
-13.0%
Q2 24
5.3%
5.9%
Q1 24
-1.7%
-9.8%
Capex Intensity
PNTG
PNTG
VATE
VATE
Q4 25
1.2%
Q3 25
1.5%
0.1%
Q2 25
1.4%
Q1 25
0.9%
1.7%
Q4 24
1.8%
3.0%
Q3 24
0.5%
1.3%
Q2 24
1.0%
1.0%
Q1 24
2.0%
1.8%
Cash Conversion
PNTG
PNTG
VATE
VATE
Q4 25
2.43×
Q3 25
2.29×
Q2 25
4.89×
Q1 25
-2.73×
Q4 24
3.57×
Q3 24
1.24×
Q2 24
1.84×
1.49×
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PNTG
PNTG

Home Health Subsegment$136.2M47%
Hospice Subsegment$97.1M34%
Private And Other$36.4M13%
Medicare And Medicaid$19.6M7%
Affiliated Entity$2.2M1%

VATE
VATE

Commercial Revenue$126.1M33%
Industrial Revenue$87.5M23%
Transportation Revenue$58.4M15%
Healthcare Revenue$48.4M13%
Government Revenue$44.3M12%
Energy Revenue$8.0M2%
Broadcast Station Revenue$5.7M1%
Systems And Consumables Revenue$3.1M1%
Leisure Revenue$200.0K0%

Related Comparisons